US Patent 7435818 Crystal forms of irinotecan hydrochloride
Patent 7435818 was granted and assigned to ScinoPharm Taiwan on October, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Piin-Jye Harn0
Shu-Ping Chen0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+274 characters)
Article
Patent abstract
The present invention provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating metastatic carcinoma of the colon or rectum using same.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07435818 Crystal forms of irinotecan hydrochloride US Patent 7435818 Crystal forms of irinotecan hydrochloride
Infobox
Patent Number
074358180
Patent Number
74358180
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074358180
Date of Patent
October 14, 2008
0Patent Application Number
115233670
Date Filed
September 19, 2006
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07435818 Crystal forms of irinotecan hydrochloride
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07435818
Date of patent
October 14, 2008
Patent application number
11523367
Date Filed
September 19, 2006
Patent primary examiner
Find more entities like US Patent 7435818 Crystal forms of irinotecan hydrochloride
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.